Related Experiment Video
Updated: May 1, 2026
05:46
A Novel Inhalation Mask System to Deliver High Concentrations of Nitric Oxide Gas in Spontaneously Breathing Subjects
Published on: May 4, 2021
5.3K
Exhaled nitric oxide in interstitial lung diseases.
P Cameli1, E Bargagli1, R M Refini1
1Department of Medical and Surgical Sciences and Neurosciences, Respiratory Disease and Lung Transplantation Section, Le Scotte Hospital, Siena, Italy.
Respiratory Physiology & Neurobiology
|April 8, 2014
Summary
Idiopathic interstitial pneumonia patients exhibit elevated nitric oxide (NO) levels. Alveolar NO concentration (CalvNO) correlates with lung function and exercise capacity, suggesting its potential as a biomarker for lung fibrosis.
Area of Science:
- Respiratory Medicine
- Biomarkers
- Pulmonary Physiology
Background:
- Nitric oxide (NO) is implicated in nitrosative stress and the pathogenesis of idiopathic interstitial pneumonias (IIP).
- Assessing exhaled NO and alveolar NO concentration (CalvNO) can provide insights into IIP.
- Pulmonary function tests (PFT) and 6-minute walking tests (6MWT) are crucial for evaluating IIP progression.
Purpose of the Study:
- To evaluate exhaled NO levels in IIP patients.
- To correlate alveolar NO concentration (CalvNO) with PFT and 6MWT parameters in IIP.
- To explore the potential of CalvNO as a biomarker for lung fibrosis and exercise tolerance.
Main Methods:
- Measured fractional exhaled nitric oxide (FeNO), CalvNO, and maximum conducting airway wall flux (J'awNO).
- Included 30 healthy subjects and 30 IIP patients (22 idiopathic pulmonary fibrosis, 8 idiopathic non-specific interstitial pneumonias).
- Analyzed correlations between CalvNO, PFT parameters (TLC, FVC, TLCO), and 6MWT outcomes (distance, recovery time).
Main Results:
- IIP patients demonstrated significantly higher FeNO and CalvNO compared to healthy controls (p<0.0001).
- CalvNO showed significant correlations with 6-minute walking distance (p<0.0001), recovery time (p<0.0005), TLC (p<0.001), FVC (p=0.01), and TLCO (p<0.01).
- Abnormal NO production in IIP likely results from lung fibrosis and oxidative injury.
Conclusions:
- IIP patients exhibit altered nitric oxide production.
- CalvNO is a potential biomarker for assessing lung fibrosis severity.
- CalvNO correlates with exercise tolerance, offering a non-invasive measure for IIP management.
Related Concept Videos
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
5.0K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
5.0K
01:20COPD: Pathogenesis and Clinical Features
2.1K
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
2.1K
01:28Nitric Oxide Signaling Pathway
5.3K
Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
5.3K
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
40
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
40
01:29Pneumonia I: Introduction
24
Pneumonia is an infection of the lower respiratory tract that leads to inflammation of the lung parenchyma, often resulting in the accumulation of inflammatory exudate in the alveoli and airways. Unlike the watery, low-protein fluid exudate in pulmonary edema, the exudate in this case is a thick fluid rich in immune cells, proteins, and debris produced during infection and inflammation.This impairs gas exchange and can lead to consolidation of lung tissue. The infection may be caused by a...
24
01:23Chronic Obstructive Pulmonary Disease II: Emphysema
48
Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
48